Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Katherine Parker currently holds 62,797 shares of ENDOCYTE INC (ECYT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katherine Parker has been a net seller of ECYT stock. They have purchased $0 and sold $210.6K worth of shares.
Katherine Parker's most recent insider trade was on Dec 21, 2018, when they sold 12,500 shares at $24.00 per share.
Katherine Parker serves as Executive at ENDOCYTE INC (ECYT). They have executed 12 insider transactions totaling $210.6K over their tenure at the company.
Katherine Parker holds the position of Executive at ENDOCYTE INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Katherine Parker has shown a selling trading pattern, with $0 in total purchases and $210.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Katherine Parker was on Dec 21, 2018, when they sold $547.1K worth of ECYT shares. This transaction involved 22,797 shares at $24.00 per share.
Katherine Parker currently owns 62,797 shares of ENDOCYTE INC (ECYT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Katherine Parker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Katherine Parker has 12 Form 4 filings on record as an insider at ENDOCYTE INC.
Set alerts for Katherine Parker and 40,000+ other insiders.